Get the Stockscreener App
2.00
0.99%
-0.02
After Hours:
1.99
-0.01
-0.50%
Nucana Plc Adr stock is traded at $2.00, with a volume of 21,012.
It is down -0.99% in the last 24 hours and down -2.91% over the past month.
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States and the United Kingdom.
See More
Previous Close:
$2.02
Open:
$1.97
24h Volume:
21,012
Relative Volume:
0.53
Market Cap:
$8.32M
Revenue:
-
Net Income/Loss:
$-38.99M
P/E Ratio:
-0.0149
EPS:
-134.6096
Net Cash Flow:
$-9.67M
1W Performance:
+1.01%
1M Performance:
-2.91%
6M Performance:
-49.62%
1Y Performance:
-73.68%
1-Day Range:
$1.97
$2.04
1-Week Range:
$1.9543
$2.08
52-Week Range:
$1.33
$40.00
Nucana Plc Adr Stock (NCNA) Company Profile
Compare NCNA vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NCNA
Nucana Plc Adr
|
2.00 | 8.41M | 0 | -38.99M | -9.67M | -134.61 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Nucana Plc Adr Stock (NCNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-30-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Mar-03-22 | Downgrade | Cowen | Outperform → Market Perform |
| Oct-22-20 | Initiated | Truist | Buy |
| Jul-24-20 | Initiated | Oppenheimer | Outperform |
| Aug-19-19 | Initiated | H.C. Wainwright | Buy |
| Oct-19-18 | Initiated | Piper Jaffray | Overweight |
| Oct-23-17 | Initiated | Citigroup | Buy |
| Oct-23-17 | Initiated | Jefferies | Buy |
| Oct-23-17 | Initiated | William Blair | Outperform |
View All
Nucana Plc Adr Stock (NCNA) Latest News
Buying pressure lifts NuCana stock higher in today's trading - Traders Union
NCNA Stock Chart | NUCANA PLC-ADR (NASDAQ:NCNA) - ChartMill
NuCana shares dip amid rising selling pressure - Traders Union
NuCana stock climbs 3.03% as price holds in tight $2.00–$2.08 range - Traders Union
NuCana shares jump as stock buying pressure builds - Traders Union
NuCana stock price forecast: $2.31 resistance as NCNA posts 10.10% gain - Traders Union
NuCana Reports First Quarter 2026 Financial Results and Provides Business Update - ChartMill
What triggered NuCana shares' latest price surge - Traders Union
+3.23% for NuCana stock as price rebounds after pronounced underperformance - Traders Union
What is behind NuCana stock's recent drop in value today - Traders Union
NuCana publishes 2025 annual report and schedules annual general meeting - Investing.com
NuCana (NASDAQ: NCNA) outlines 2025 loss, cash runway and key 2026 AGM capital votes - Stock Titan
NuCana stock price forecast: $1.83 support in focus as NCNA drops 3.17% - Traders Union
NCNA News | NUCANA PLC-ADR (NASDAQ:NCNA) - ChartMill
NuCana stock price forecast: $2.25 resistance as NCNA gains 3.92% - Traders Union
Stuck in a narrow $2.02–$2.30 range lifts NuCana stock 4.31% - Traders Union
Unusual Machines, NuCana, Navigator Holdings and other big stocks moving lower in Friday's pre-market session - MSN
NuCana stock price forecast: $2.41 resistance eyed as NCNA moves down 4.37% - Traders Union
Overbought levels pause NuCana stock advance near recent highs - Traders Union
+5.10% for NuCana stock as overbought conditions emerge - Traders Union
+8.63% for NuCana stock as fresh highs prompt overbought signals - Traders Union
NuCana stock price forecast: $2.05–$2.40 range as NCNA gains 18.42% - Traders Union
-6.83% for NuCana stock as tight trading range restricts moves - Traders Union
NuCana stock rises after bouncing from $1.60 support - Traders Union
NuCana plc Stock: Prodrug Technology Platform Targets Oncology Challenges for Long-Term Investor Val - AD HOC NEWS
Bearish signals and low breakout odds keep NuCana stock near resistance - Traders Union
NuCana plc Stock: Clinical-Stage Biotech Innovating Cancer Therapies with ProTide Technology - AD HOC NEWS
-3.18% for NuCana stock as price stays pinned below key support levels - Traders Union
What triggered NuCana shares' latest price pullback - Traders Union
Negative indicators push NuCana stock lower amid continued selling activity - Traders Union
Selling pressure pushes NuCana stock lower in today's trading - Traders Union
What is behind NuCana stock's recent gain in value today - Traders Union
Technical weakness and oversold signals: NuCana stock falls 3.22% - Traders Union
NuCana shares see a dip: what is pressuring the stock - Traders Union
Unusual Machines, NuCana, Navigator Holdings And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
NuCana (NASDAQ: NCNA) outlines 2025 losses, cash and oncology pipeline risks - Stock Titan
NuCana Reports Fourth Quarter and Year-End 2025 Financial Results and Provides Business Update - ChartMill
Nucana Plc Adr Stock (NCNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
0.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):